Abstract
Introduction blotting (to analyze consistent loading of intact protein with β-actin as a loading control). Lysates 184 were used in the Proteome Profiler Human Phospho-Kinase Array (R&D cat. ARY003b) 185 according to the manufacturer's instructions. Membranes were exposed to x-ray films and 186 visualized on a light box. The same procedure was used to generate lysates for ELISAs, and p-187 CREB levels were quantified using DuoSet IC Human/Mouse/Rat Phospho-CREB (S133)
188
ELISA kits (R&D Systems).
190
Migration, invasion, proliferation, soft agar, spheroid growth assays and cell-cell adhesion assays 191 For migration and invasion assays, a total of 500 µL of DMEM (with 10% FBS and 1% 
211
For monolayer proliferation assays, 25,000 cells per well were plated in 500 µL of 212 DMEM in 24-well plates, and percent confluence was analyzed using the IncuCyte Zoom 213 software, with imaging at two hour intervals at 100X total magnification.
214
Soft agar anchorage-independent growth assays were performed as previously described supplemented DMEM in 6-well plates. Media was replenished weekly, after which colonies were 218 stained with Nitrotetrazoleum Blue overnight, plates were imaged, and colonies counted using ImageJ.
220
For spheroid growth assays, cells were scraped in fully supplemented DMEM, and 1,000 221 cells/well were seeded in ultra-low attachment plates (Costar, cat. #7007).
222
For cell-cell adhesion assays, 12-well plates were incubated overnight with 223 0.5%BSA/Fraction V in CMFS buffer at 4°C. CMFS buffer contains 4 g NaCl, 0.2g KCl, 0.03g 224 Na 2 HPO 4 , and 0.5 g glucose diluted in 500 ml PBS (-/-). Plates were washed with CMFS buffer 225 and 200,000 cells were immediately seeded in 1mL of media. Plates were incubated on an orbital 226 shaker at 100 rpm at 37°C for 3 hours, followed by the addition of 1.5 mL of 4% PFA and 227 incubated at room temperature for 30 minutes. Cells aggregates were immediately quantified in 228 size categories using ImageJ.
229

Statistical analyses
230
All data were analyzed for statistically significant differences using the Student's t-test (for two 231 comparisons) or analysis of variance with Tukey's post-hoc correction (for multiple 232 comparisons) in JMP Pro 13. Any p-value < 0.05 was considered statistically significant.
234
Quantitative modeling for simulating the mechanical effects of E-cadherin 
Results
259
Aberrant E-cadherin expression in sarcomas is prognostic for improved clinical outcomes Our previous work found that phenotypic plasticity in sarcomas leads to a more epithelial-like 261 phenotype (Somarelli et al., 2016 cadherin protein levels ( Figure 1D ). These analyses suggest that E-cadherin has prognostic 274 utility in sarcomas.
276
Ectopic E-cadherin expression in sarcomas does not promote MET
277
While it is clear that E-cadherin has prognostic relevance in sarcomas, the underlying molecular EMT score using our previously-derived scoring metric for epithelial, mesenchymal and hybrid 295 epithelial/mesenchymal states (George et al., 2017 conditions.
332 333
E-cadherin-mediated suppression of anoikis resistance acts, in part, through CREB
334
To determine the signaling pathway(s) through which E-cadherin inhibits anoikis resistance in 
344
We next asked if E-cadherin-mediated p-CREB inhibition was responsible for the 345 reductions in anchorage-independent growth capacity of E-cadherin expressing cells. To do this,
346
we knocked down CREB using two independent siRNAs and verified knockdown at the mRNA 347 and protein levels in 143B cells, with siRNA_5 providing a stronger knockdown (Figure 4D, E) . 348 We noted a consistent reduction in soft agar growth with both CREB siRNAs compared to a non- factors are likely at play in driving anoikis resistance in sarcomas.
353
During our analysis of MET biomarkers and phenotypes in E-cadherin expressing cells,
354
we noted that groups of E-cadherin+ 143B cells lost cell surface N-cadherin expression
355
(Supplementary Figure 3A) . Interestingly, the reduction in cell surface N-cadherin was not due Figure 3F ). These results suggest that E-cadherin inhibits anoikis resistance through a pathway 366 that is independent of N-cadherin.
368
An E-cadherin/TBX2/CREB axis modulates anchorage-independent growth of sarcomas
369
To elucidate further the signaling axis that modulates E-cadherin/CREB-mediated suppression of 370 anoikis resistance, we investigated additional signaling axes that may be involved with E-371 cadherin. One of these axes, TBX2, is a transcription factor that can directly repress E-cadherin accentuates anoikis sensitivity ( Figure 6B ). However, TBX2 knockdown had no effect on 408 spheroid formation, when E-cadherin was overexpressed in U2OS cells ( Figure 6D ).
409
The inconsistency in model predictions vs. experimental observations drew our attention 
454
To quantitatively capture the relationship between cell-cell adhesion and spheroid size, Figure 5) . Thus, the model predicts that cell-cell adhesion can regulate colony 469 size through mechanical factors.
470
To test if E-cadherin modulates cell-cell adhesion in sarcomas, we quantified the Our integrated computational-experimental study illustrates that E-cadherin inhibits sarcoma 
801
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